Dianthus Therapeutics (DNTH) Shares Outstanding: 2017-2025
Historic Shares Outstanding for Dianthus Therapeutics (DNTH) over the last 7 years, with Sep 2025 value amounting to $42.9 million.
- Dianthus Therapeutics' Shares Outstanding rose 45.93% to $42.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.9 million, marking a year-over-year increase of 45.93%. This contributed to the annual value of $31.1 million for FY2024, which is 109.99% up from last year.
- As of Q3 2025, Dianthus Therapeutics' Shares Outstanding stood at $42.9 million, which was up 33.19% from $32.2 million recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Shares Outstanding registered a high of $42.9 million during Q3 2025, and its lowest value of $10.3 million during Q1 2022.
- Moreover, its 3-year median value for Shares Outstanding was $31.1 million (2024), whereas its average is $29.3 million.
- Data for Dianthus Therapeutics' Shares Outstanding shows a peak YoY increase of 222.74% (in 2023) and a maximum YoY decrease of 55.55% (in 2023) over the last 5 years.
- Quarterly analysis of 4 years shows Dianthus Therapeutics' Shares Outstanding stood at $33.3 million in 2022, then tumbled by 55.55% to $14.8 million in 2023, then skyrocketed by 109.99% to $31.1 million in 2024, then surged by 45.93% to $42.9 million in 2025.
- Its Shares Outstanding stands at $42.9 million for Q3 2025, versus $32.2 million for Q2 2025 and $32.1 million for Q1 2025.